World's Best Scientists 2026 revealed!
Jeffrey L. Probstfield

Jeffrey L. Probstfield

D-Index & Metrics

Medicine

D-Index
94
Citations
91658
World Ranking
10225
National Ranking
5258

Overview

Jeffrey L. Probstfield is affiliated with the University of Washington in the United States. Their research spans the broad field of Medicine, with a primary focus on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Emergency Medicine, Surgery, and Molecular Biology.

The scientist has contributed extensively to topics such as Diabetes Treatment and Management, Atrial Fibrillation Management and Outcomes, Antiplatelet Therapy and Cardiovascular Diseases, Venous Thromboembolism Diagnosis and Management, Metabolism, Diabetes, and Cancer, Cardiac Arrest and Resuscitation, and Cardiovascular Function and Risk Factors.

Jeffrey L. Probstfield's frequent publication venues include:

  • Resuscitation
  • Circulation
  • The Lancet Diabetes & Endocrinology
  • American Heart Journal
  • European Journal of Heart Failure

The scientist's recent papers include:

  • Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial, 2020, The Lancet Neurology
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials, 2022, The Lancet
  • Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease, 2020, Circulation
  • The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial, 2020, The Lancet Diabetes & Endocrinology
  • Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI), 2020, Circulation

Frequent co-authors of this scientist include Hertzel C. Gerstein, Kelley R. Branch, Gilles R. Dagenais, Fernando Laņas, and Nana Pogosova. These collaborations indicate active partnerships in related cardiovascular and metabolic research areas.

Best Publications

  • Effects of intensive glucose lowering in type 2 diabetes

    Hertzel C Gerstein;Michael E Miller;Robert P Byington

  • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

    Curt D. Furberg;Jackson T. Wright;Barry R Davis;Jeffrey A. Cutler

  • High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

    D. J. Gordon;J. L. Probstfield;R. J. Garrison;Jim Neaton

  • Effects of intensive blood-pressure control in type 2 diabetes mellitus.

    C. Cushman;Gregory W. Evans;Robert P. Byington;Jeffrey A. Cutler

  • Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

    Patrice Desvignes-Nickens;Kent Koprowicz;Ruth McBride;Koon Teo

  • Effects of combination lipid therapy in type 2 diabetes mellitus.

    Henry N. Ginsberg;Laura C. Lovato;Lawrence A. Leiter;Peter Linz

  • Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

    Scott M. Lippman;Eric A. Klein;Eric A. Klein;Phyllis J. Goodman;M. Scott Lucia

  • Spironolactone for Heart Failure with Preserved Ejection Fraction

    Bertram Pitt;Marc A. Pfeffer;Susan F. Assmann;Robin Boineau

  • Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Marc A. Pfeffer;Brian L. Claggett;Rafael Diaz;Kenneth Dickstein

  • Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease

    Eva Lonn;Salim Yusuf;J. Arnold;Janice Pogue

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • Design of the Women's Health Initiative clinical trial and observational study

    G. Anderson;S. Cummings;L. S. Freedman;C. Furberg

  • Basal insulin and cardiovascular and other outcomes in dysglycemia

    Origin Trial Investigators;Hertzel C Gerstein;Jackie Bosch;Gilles R Dagenais

  • Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

    William C. Cushman;Charles E. Ford;Jeffrey A. Cutler;Karen L. Margolis

  • Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

    Eva Lonn;Jackie Bosch;Salim Yusuf;Patrick Sheridan

  • Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

    R. S. McKelvie;S. Yusuf;D. Pericak;A. Avezum

  • Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.

    Salim Yusuf;Janet Wittes;Jeffrey Probstfield;Herman A. Tyroler

  • Erectile Dysfunction and Subsequent Cardiovascular Disease

    Ian M. Thompson;Catherine M. Tangen;Phyllis J. Goodman;Jeffrey L. Probstfield

  • Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

    Hertzel C. Gerstein;Michael E. Miller;Saul Genuth;Faramarz Ismail-Beigi

  • Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

    Matthew J McQueen;Steven Hawken;Xingyu Wang;Stephanie Ounpuu

Frequent Co-Authors

Salim Yusuf
Salim Yusuf McMaster University
Hertzel C. Gerstein
Hertzel C. Gerstein McMaster University
Rafael Diaz
Rafael Diaz University of Alberta
Barry R. Davis
Barry R. Davis The University of Texas Health Science Center at Houston
Jackie Bosch
Jackie Bosch McMaster University
Gilles R. Dagenais
Gilles R. Dagenais Université Laval
Aldo P. Maggioni
Aldo P. Maggioni Heart Care Foundation, ANMCO Research Center, Florence
Lars Rydén
Lars Rydén Karolinska Institute
William C. Cushman
William C. Cushman University of Tennessee Health Science Center
Alvaro Avezum
Alvaro Avezum Population Health Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying medicine in the USA opens doors to a wide range of healthcare careers beyond traditional medical school. Many students begin their journey by pursuing nursing. For prospective students who want a direct route into nursing, some may benefit from a nursing school that doesn't require teas or HESI exams, offering an alternative path to enter the field quickly.

If you’re interested in the administrative side of healthcare, online health administration programs can prepare you for leadership roles in hospitals, clinics, and other healthcare organizations. These flexible degrees are ideal for those looking to balance studies with existing commitments.

For nurses seeking career advancement, bridge programs like adn to np provide a streamlined path to becoming a Nurse Practitioner, expanding both clinical skills and job opportunities.

Additionally, students passionate about preventative health and nutrition can explore online nutrition degree programs to build expertise in dietetics and wellness.

Each of these educational pathways can complement or provide alternatives to a traditional medicine degree, broadening your options within the healthcare industry.

Best Scientists Citing Jeffrey L. Probstfield

Trending Scientists

Recently Published Articles